Valeo Pharma Inc (VPH)

Toronto
0.52
0.00(0.00%)
  • Volume:
    17,500
  • Bid/Ask:
    0.51/0.53
  • Day's Range:
    0.52 - 0.53

VPH Overview

Prev. Close
0.52
Day's Range
0.52-0.53
Revenue
36.66M
Open
0.52
52 wk Range
0.45-0.69
EPS
-0.32
Volume
17,500
Market Cap
43.65M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
22,670
P/E Ratio
-1.53
Beta
2.48
1-Year Change
-21.21%
Shares Outstanding
83,937,228
Next Earnings Date
Jul 06, 2023
What is your sentiment on Valeo Pharma?
or
Market is currently closed. Voting is open during market hours.

Valeo Pharma Inc Company Profile

Valeo Pharma Inc Company Profile

Employees
115
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA91915B1085
  • CUSIP:91915B108

Valeo Pharma Inc. is a Canada-based specialty pharmaceutical company. The Company acquires or in-licenses brand and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology, specialty products, hospital generic division. Its respiratory/allergy products include Enerzair, Breezhaler, Atectura, Breezhaler and Allerject. Its ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis, Hesperco and Ametop Gel 4%. Its hospital generic division includes Benztropine, Ethacrynate Sodium and Amikacin. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

Read More

Analyst Price Target

Average1.48 (+183.65% Upside)
High2.40
Low1.00
Price0.52
No. of Analysts4
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Sell
Technical IndicatorsBuyBuyBuySellStrong Sell
SummaryNeutralNeutralNeutralSellStrong Sell